Some biotech companies are offering a new way to soften the shock of drug prices: Insurers pay only if the patient improves

Quick Read

Our Leonard Rubenstein led a project that resulted in a report and recommendations responding to the ethical challenges in humanitarian health in situations of extreme violence. Read the full report now

Quick Read

Administrators at the MD Anderson Cancer Center in Houston, Texas, yesterday tried to reassure alarmed employees that its recent dismissals of faculty members alleged to have broken federal funding rules were not connected to race or ethnicity

Quick Read

Dr. Richard Valery Mouzoko Kiboung arrived in Democratic Republic of the Congo just four weeks ago – one of hundreds of disease experts that the World Health Organization has recruited to help curb the ongoing Ebola outbreak there

Quick Read

Updated regulations allow scientists to use some genome-editing techniques in plants and animals without government approval

Quick Read

But the practical challenges of breeding and maintaining unconventional lab animals persist

Quick Read

Neil Levy writes, “Neuroethics is exciting. It is fascinating to consider the deep issues it raises and the future possibilities it explores. I worry, however, that the focus on the exciting possibilities of present and future neuroscience obscures more pressing ethical issues.”

Quick Read

Lou Ortenzio was a trusted West Virginia doctor who got his patients—and himself—hooked on opioids. Now he’s trying to rescue his community from an epidemic he helped start

Quick Read